Alendronate Unicorn 70 mg Tablets

Indication

Treatment and prevention of osteoporosis in postmenopausal women and in men at high risk of fracture.

Dosage (summary)

One 70 mg tablet taken orally once weekly, preferably on the same day each week.

Onset of Action / Duration

Effects on bone mineral density may be observed after 3 to 6 months of treatment.

Special Populations

• Elderly patients
• Patients with renal impairment
• Patients with a history of gastrointestinal disorders

Pregnancy & Breastfeeding

Not recommended during pregnancy and lactation due to potential risks to the fetus or nursing infant.

Key Drug Interactions

• Antacids may reduce absorption; separate dosing by at least 2 hours.
• Calcium supplements may interfere with absorption; take at different times.
• NSAIDs may increase the risk of gastrointestinal side effects.

Contraindications

• Hypersensitivity to alendronate or any component of the formulation.
• Esophageal abnormalities that delay esophageal emptying.
• Inability to stand or sit upright for at least 30 minutes.
• Severe renal impairment (creatinine clearance < 35 mL/min).

Common side effects

• Gastrointestinal disturbances (nausea, abdominal pain, dyspepsia).
• Musculoskeletal pain.
• Hypocalcemia.
• Osteonecrosis of the jaw (rare).

Counselling Points

• Instruct patients to take the tablet with a full glass of water.
• Advise patients to remain upright for at least 30 minutes after taking the medication.
• Inform patients about the importance of adequate calcium and vitamin D intake.
• Discuss potential side effects and the importance of reporting any unusual symptoms.